Nicorama Mint (Nicotine)

Nicotine, the active ingredient in Nicorama Mint, is a nicotinic receptor agonist presented as an unknown/unknown for oral use. It treats smoking cessation in adults by reducing nicotine withdrawal symptoms. GNH USA supplies Nicorama Mint as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicorama Mint is a nicotinic receptor agonist used in the management of nicotine dependence and smoking cessation. - Smoking cessation: helps adults reduce withdrawal symptoms and quit tobacco use. - Nicotine dependence: supports reduction of cravings in individuals attempting to stop smoking. - Relapse prevention: assists former smokers in maintaining abstinence.

Adverse reactions may occur with oral nicotine products and should be monitored.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: transient feeling of queasiness. - Dizziness: light‑headed sensation, especially on initial use. - Headache: mild to moderate intensity. - Insomnia: difficulty falling or staying asleep. - Increased salivation: excess saliva production.

Serious or Rare Side Effects: - Cardiovascular events: chest pain, palpitations, or hypertension. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Arrhythmia: irregular heart rhythm. - Hypertension: elevated blood pressure. - Seizures: rare convulsive episodes. - Respiratory depression: reduced breathing effort.

Use Nicorama Mint with caution and follow professional guidance. - Contraindication: known hypersensitivity to nicotine. - Cardiovascular disease: assess risk before use. - Pregnancy: safety not established; consult a healthcare provider. - Breastfeeding: potential exposure to infant; discuss with a clinician. - Minors: not recommended for individuals under the legal age for tobacco products. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture and heat.

Nicotine may interact with other medications, requiring attention to potential effects.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase hypertensive response. - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Other nicotine replacement therapies: risk of nicotine overdose.

Moderate Interactions (Monitor Closely): - Caffeine: may enhance jitteriness or palpitations. - Alcohol: may increase sedative effects. - Antidepressants (SSRIs): monitor for heightened side‑effects.